Anthony P. Conley

Emerging therapeutic strategies and clinical development of investigational agents for conventional chondrosarcoma

Introduction Conventional chondrosarcoma (cCS) is a malignant bone tumor withintrinsic resistance to cytotoxic therapy. Advances in genomic profiling have revealed recurrent alterations that are redefining the therapeutic landscape for these tumors.Areas covered Literature search...